Abvc Biopharma ABVC
NASDAQ ABVC
$1.01 -0.01 (-0.98%)
At close: Oct 2, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Selling, General & Administrative (2010 - 2026)

Updated

Abvc Biopharma's Selling, General & Administrative came in at $503,778 for Q2 2026, down 27.0% from $690,094 a year earlier and down 33.0% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Abvc Biopharma reported Selling, General & Administrative of $2.84 million, up 30.5% year-over-year; for FY2025, it came in at $2.89 million, up 27.7% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of -7.5% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $2.26 million in FY2024 (-57.9%), $5.37 million in FY2023 (-11.5%), $6.07 million in FY2022 (+5.6%) and $5.75 million in FY2021 (+34.5%).
  • The Q2 2026 figure represents the lowest quarterly Selling, General & Administrative since Q4 2024.
  • Year-over-year, Selling, General & Administrative increased in four of the last eight quarters, with growth averaging 5.8%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q4 2025 (growth of 151.6%), and the weakest in Q4 2022 (a decline of 96.2%).
  • Business Quant data shows ABVC's Selling, General & Administrative at $751,998 (Q1 2026), $783,640 (Q4 2025) and $798,253 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Abvc Biopharma 26.28 Mn 28.27 Mn - 503,778.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 503,778.00
Mar 31, 2026 751,998.00
Dec 31, 2025 783,640.00
Sep 30, 2025 798,253.00
Jun 30, 2025 690,094.00
Mar 31, 2025 615,371.00
Dec 31, 2024 311,471.00
Sep 30, 2024 557,596.00
Jun 30, 2024 653,783.00
Mar 31, 2024 738,486.00
Dec 31, 2023 1.53 Mn
Sep 30, 2023 1.18 Mn
Jun 30, 2023 1.39 Mn
Mar 31, 2023 1.27 Mn
Dec 31, 2022 67,490.00
Sep 30, 2022 3.22 Mn
Jun 30, 2022 1.59 Mn
Mar 31, 2022 1.19 Mn
Dec 31, 2021 1.77 Mn
Sep 30, 2021 1.58 Mn
API Access

Abvc Biopharma Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ABVC&period=max&api_key=YOUR_API_KEY